Magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) is a rapidly developing technique used for tremor relief in tremor-predominant Parkinson’s disease (PD) and essential tremor that has demonstrated successful results. Here, we describe the neuropathological findings in a woman who died from a fall 10 days after successful MRgFUS for tremor-predominant PD. Histological analysis demonstrates the characteristic early postoperative MRI findings including 3 distinct zones on T2-weighted imaging: (1) a hypointense core, (2) a hyperintense region with hypointense rim, and (3) a slightly hyperintense, poorly marginated surrounding area. Histopathological analyses also demonstrate the suspected cellular processes composing each of these regions including central hemorrhagic necrosis with surrounding cytotoxic edema and a rim of mostly unaffected vasogenic edema with some reactive and reparative processes. Overall, this case demonstrates the correlation of postoperative imaging findings with the subacute neuropathological findings after MRgFUS for PD.

Keywords:
Focused ultrasound, Movement disorder surgery, Parkinson’s disease, Stereotactic thalamotomy, Tremor, Ventral intermediate nucleus
1.
Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135(Pt 11):3206–26.
2.
Ghanouni P, Pauly KB, Elias WJ, Henderson J, Sheehan J, Monteith S, et al. Transcranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications. AJR Am J Roentgenol. 2015;205(1):150–9.
3.
Schlesinger I, Sinai A, Zaaroor M. MRI-guided focused ultrasound in Parkinson’s disease: a review. Parkinsons Dis. 2017;2017:8124624.
4.
Fasano A, Lozano AM, Cubo E. New neurosurgical approaches for tremor and Parkinson’s disease. Curr Opin Neurol. 2017;30(4):435–46.
5.
Lennon JC, Hassan I. Magnetic resonance-guided focused ultrasound for Parkinson’s disease since ExAblate, 2016–2019: a systematic review. Neurol Sci. 2021;42(2):553–63.
6.
Segar DJ, Lak AM, Lee S, Harary M, Chavakula V, Lauro P, et al. Lesion location and lesion creation affect outcomes after focused ultrasound thalamotomy. Brain. 2021;144(10):3089–100.
7.
Wintermark M, Druzgal J, Huss DS, Khaled MA, Monteith S, Raghavan P, et al. Imaging findings in MR imaging: guided focused ultrasound treatment for patients with essential tremor. AJNR Am J Neuroradiol. 2014;35(5):891–6.
8.
Harary M, Essayed WI, Valdes PA, McDannold N, Cosgrove GR. Volumetric analysis of magnetic resonance: guided focused ultrasound thalamotomy lesions. Neurosurg Focus. 2018;44:E6.
9.
Koga S, Ishaque M, Jeffrey Elias W, Shah BB, Murakami A, Dickson DW. Neuropathology of Parkinson’s disease after focused ultrasound thalamotomy. NPJ Parkinsons Dis. 2022;8:59–6.
10.
McDannold N, Jason White P, Rees Cosgrove G. MRI-based thermal dosimetry based on single-slice imaging during focused ultrasound thalamotomy. Phys Med Biol. 2020;65(23):235018.
11.
Rahaman P, Del Bigio MR. Histology of brain trauma and hypoxia-ischemia. Acad Forensic Pathol. 2018;8(3):539–54.
12.
Shi K, Tian D-C, Li Z-G, Ducruet AF, Lawton MT, Shi F-D. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–66.
13.
Beez T, Steiger H-J, Etminan N. Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis: a systematic review and meta-analysis. BMC Neurol. 2017;17(1):209.
14.
Vykhodtseva N, Sorrentino V, Jolesz FA, Bronson RT, Hynynen K. MRI detection of the thermal effects of focused ultrasound on the brain. Ultrasound Med Biol. 2000;26(5):871–80.
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.